Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I.

Wahezi DM, Ilowite NT, Wu XX, Pelkmans L, Laat B, Schanberg LE, Rand JH; Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators.

Lupus. 2013 Jun;22(7):702-11. doi: 10.1177/0961203313490241. Epub 2013 May 20.

PMID:
23690366
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases.

Wahezi DM, Ilowite NT, Rajpathak S, Rand JH.

J Rheumatol. 2012 Feb;39(2):382-8. doi: 10.3899/jrheum.110768. Epub 2011 Dec 15.

PMID:
22174207
[PubMed - indexed for MEDLINE]
3.

Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.

Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Iwatani Y, Kanakura Y.

Clin Chem. 2001 Jun;47(6):1008-15.

PMID:
11375285
[PubMed - indexed for MEDLINE]
Free Article
4.

Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.

Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.

J Rheumatol. 1998 Apr;25(4):667-74.

PMID:
9558167
[PubMed - indexed for MEDLINE]
5.

Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.

de Laat B, Wu XX, van Lummel M, Derksen RH, de Groot PG, Rand JH.

Blood. 2007 Feb 15;109(4):1490-4. Epub 2006 Oct 19.

PMID:
17053060
[PubMed - indexed for MEDLINE]
Free Article
6.

Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.

de Laat B, Mertens K, de Groot PG.

Nat Clin Pract Rheumatol. 2008 Apr;4(4):192-9. doi: 10.1038/ncprheum0740. Epub 2008 Feb 19. Review.

PMID:
18285765
[PubMed - indexed for MEDLINE]
7.

Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.

Woo KS, Kim KE, Kim JM, Han JY, Chung WT, Kim KH.

Korean J Lab Med. 2010 Feb;30(1):38-44. doi: 10.3343/kjlm.2010.30.1.38.

PMID:
20197721
[PubMed - indexed for MEDLINE]
Free Article
8.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
[PubMed - indexed for MEDLINE]
9.

Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.

Nojima J, Kuratsune H, Suehisa E, Iwatani Y, Kanakura Y.

Clin Chem. 2005 Mar;51(3):545-52. Epub 2005 Jan 6.

PMID:
15637132
[PubMed - indexed for MEDLINE]
Free Article
10.

Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus.

Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Kitani T, Iwatani Y, Kanakura Y.

Br J Haematol. 2001 Sep;114(3):647-54.

PMID:
11552993
[PubMed - indexed for MEDLINE]
11.

Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.

Nojima J, Kuratsune H, Suehisa E, Kawasaki T, Machii T, Kitani T, Iwatani Y, Kanakura Y.

Br J Haematol. 2002 Aug;118(2):577-83.

PMID:
12139749
[PubMed - indexed for MEDLINE]
12.

Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.

Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.

Autoimmunity. 2009 Sep;42(6):497-506. doi: 10.1080/08916930902882731.

PMID:
19626489
[PubMed - indexed for MEDLINE]
13.

IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.

Tubach F, Hayem G, Marchand JL, Weber M, Palazzo E, de Bandt M, Roux S, Kahn MF, Meyer O.

J Rheumatol. 2000 Jun;27(6):1437-43.

PMID:
10852267
[PubMed - indexed for MEDLINE]
14.

Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort.

Petri M.

Lupus. 2010 Apr;19(4):419-23. doi: 10.1177/0961203309360541.

PMID:
20353980
[PubMed - indexed for MEDLINE]
15.

[Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus].

Nojima J.

Rinsho Byori. 2003 Mar;51(3):239-47. Review. Japanese.

PMID:
12707997
[PubMed - indexed for MEDLINE]
16.

Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus.

Hrycek A, Cieślik P.

Rheumatol Int. 2012 May;32(5):1335-42. doi: 10.1007/s00296-011-1793-2. Epub 2011 Feb 5.

PMID:
21298269
[PubMed - indexed for MEDLINE]
17.

Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody.

Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto M.

Am J Hematol. 1994 Sep;47(1):56-8.

PMID:
8042617
[PubMed - indexed for MEDLINE]
18.

Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.

Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.

Ann Rheum Dis. 2008 Mar;67(3):395-401. Epub 2007 Jul 20.

PMID:
17644539
[PubMed - indexed for MEDLINE]
19.

[Antiphospholipid syndrome and stroke].

Kitagawa Y.

Rinsho Shinkeigaku. 2005 Nov;45(11):852-5. Japanese.

PMID:
16447744
[PubMed - indexed for MEDLINE]
20.

Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.

Gómez-Pacheco L, Villa AR, Drenkard C, Cabiedes J, Cabral AR, Alarcón-Segovia D.

Am J Med. 1999 Apr;106(4):417-23.

PMID:
10225244
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk